Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 25, Issue 11, 1998, Pages 1771-1774

  Kobayashi, M ^a   Sugaya, Y ^a   Yuzawa, M ^a   Ochi, M ^a   Morita, T ^a   Kobayashi, Y ^a   Tokue, A ^a   Hara, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG DERIVATIVE; PIRARUBICIN;

ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; DRUG ADMINISTRATION; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; PATHOLOGY;

ADMINISTRATION, INTRAVESICAL; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 0032160328     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)